Phosphaturic mesenchymal tumor, mixed connective tissue variant, of the mandible: report of a case and review of the literature

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 108, Issue 6, 2009, Pages 925-932

  Woo, Victoria L ^a   Landesberg, Regina ^b   Imel, Erik A ^c   Singer, Steven R ^d   Folpe, Andrew L ^e   Econs, Michael J ^c   Kim, Taeyun ^d   Harik, Lara R ^f   Jacobs, Thomas P ^f  

^a UNIVERSITY OF NEVADA   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^c INDIANA UNIVERSITY   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e MAYO CLINIC   (United States)

^f NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CONNECTIVE TISSUE TUMOR; FEMALE; HUMAN; HYPOPHOSPHATEMIA; MANDIBLE TUMOR; MESENCHYMOMA; OSTEOMALACIA; PARANEOPLASTIC SYNDROME; PATHOLOGY;

ADULT; FEMALE; HUMANS; HYPOPHOSPHATEMIA; MANDIBULAR NEOPLASMS; MESENCHYMOMA; NEOPLASMS, CONNECTIVE TISSUE; OSTEOMALACIA; PARANEOPLASTIC SYNDROMES;

EID: 72149083852     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2009.07.005     Document Type: Article

References (45)

1. Folpe A.L., Fanburg-Smith J.C., Billings S.D., Bisceglia M., Bertoni F., Cho J.Y., et al. Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: An analysis of 32 cases and a comprehensive review of the literature. Am J Surg Pathol 28 (2004) 1-30
2. Drezner M.K. Tumor-induced osteomalacia. Rev Endocr Metab Disord 2 (2001) 175-186
3. Siris E.S., Clemens T.L., Dempster D.W., Shane E., Segre G.V., Lindsay R., et al. Tumor-induced osteomalacia. Kinetics of calcium, phosphorus, and vitamin D metabolism and characteristics of bone histomorphometry. Am J Med 82 (1987) 307-312
4. Kaul M., Silverberg M., DiCarlo E.F., Schneider R., Bass A.R., and Erkan D. Tumor-induced osteomalacia. Clin Rheumatol 26 (2007) 1575-1579
5. Schapira D., Izhak O.B., Nachtigal A., Burstein A., Shalom R.B., Shagrawi I., et al. Tumor-induced osteomalacia. Semin Arthritis Rheum 25 1 (1995) 35-46
6. Ungari C., Rocchi G., Rinna C., Agreillo A., Lattanzi A., and Pagnoni M. Hypophosphaturic mesenchymal tumor of the ethmoid associated with oncogenic osteomalacia. J Craniofac Surg 15 3 (2004) 523-527
7. Weidner N., and Santa Cruz D. Phosphaturic mesenchymal tumors. A polymorphous group causing osteomalacia or rickets. Cancer 59 (1987) 1442-1454
8. Reis-Filho J.S., Paiva M.E., and Lopes J.M. Pathologic quiz case: A 36-year-old woman with muscle pain and weakness. Arch Pathol Lab Med 126 10 (2002) 1245-1246
9. Reyes-Múgica M., Arnsmeier S.L., Backeljauw P.F., Persing J., Ellis B., and Carpenter T.O. Phosphaturic mesenchymal tumor-induced rickets. Pediatr Dev Pathol 3 (2000) 61-69
10. Larsson T., Zahradnik R., Lavigne J., Ljunggren Ö., Jüppner H., and Jonsson K. Immunohistochemical detection of FGF-23 protein in tumors that cause oncogenic osteomalacia. Eur J Endocrinol 148 (2003) 269-276
11. Rhee Y., Lee J.D., Shin K.H., Lee C.H., Huh K.B., and Lim S.-K. Oncogenic osteomalacia associated with mesenchymal tumor detected by indium-111 octreotide scintigraphy. Clin Endocrinol 54 (2001) 551-554
12. Evans D.J., and Azzopardi J.G. Distinctive tumours of bone and soft tissue causing acquired vitamin-D-resistant osteomalacia. Lancet 1 (1972) 353-354
13. Olefsky J., Kempson R., Jones H., and Reaven G. "Tertiary" hyperparathyroidism and apparent "cure" of vitamin-D-resistant rickets after removal of an ossifying mesenchymal tumor of the pharynx. N Engl J Med 286 (1972) 740-745
14. Imel E.A., Peacock M., Pitukcheewanont P., Heller H.J., Ward L.M., Shulman D., et al. Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia. J Clin Endocrinol Metab 91 6 (2006) 2055-2061
15. Econs M.J., and McEnery P.T. Autosomal dominant hypophosphatemic rickets/osteomalacia: clinical characterization of a novel renal phosphate wasting disorder. J Clin Endocrinol Metab 82 2 (1997) 674-681
16. Bijvoet O.L.M. Relation of plasma phosphate concentration to renal tubular resorption of phosphate. Clin Sci 37 (1969) 23-36
17. Yamazaki Y., Okazaki R., Shibata M., Hasegawa Y., Satoh K., Tajima T., et al. Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia. J Clin Endocrinol Metab 87 11 (2002) 4957-4960
18. Weiss D., Bar R.S., Weidner N., Wener N., and Lee F. Oncogenic osteomalacia: strange tumours in strange places. Postgrad Med J 61 (1985) 349-355
19. Nomura G., Koshino Y., Morimoto H., Kida H., Nomura S., and Tamai K. Vitamin D resistant hypophosphatemic osteomalacia associated with osteosarcoma of the mandible: report of a case. Jpn J Med 21 1 (1982) 35-39
20. Yang I.M., Park Y.K., Hyun Y.J., Kim D.Y., Woo J.T., Kim S.W., et al. Oncogenic osteomalacia caused by a phosphaturic mesenchymal tumor of the oral cavity: a case report. Korean J Intern Med 12 (1997) 89-95
21. Dupond J.L., Mahammedi H., Prié D., Collin F., Gil H., Blagosklonov O., et al. Oncogenic osteomalacia: diagnostic importance of fibroblast growth factor 23 and F-18 fluorodeoxyglucose PET/CT SCAN for the diagnosis and follow-up in one case. Bone 36 (2005) 375-378
22. Ahn J.-M., Kim H.-K., Cha C.-M., Kim J., Yim S.-G., and Kim H.J. Oncogenic osteomalacia: induced by tumor, cured by surgery. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103 (2007) 636-641
23. Kim Y.G., Choi Y.S., Lee S.C., and Ryu D.M. Tumor-induced osteomalacia associated with lesions in the oral and maxillofacial region: report of two cases. J Oral Maxillofac Surg 54 (1996) 1352-1357
24. Nitzan D.W., Horowitz A.T., Darmon D., Friedlaender M.M., Rubinger D., Stein P., et al. Oncogenous osteomalacia: a case study. Bone Miner 6 (1989) 191-197
25. Avila N.A., Skarulis M., Rubino D.M., and Doppman J.L. Oncogenic osteomalacia: lesion detection by MR skeletal survey. AJR Am J Roentgenol 167 (1996) 343-345
26. Yun K.-I., Kim D.-H., and Pyo S.-W. A phosphaturic mesenchymal tumor of the floor of the mouth with oncogenic osteomalacia. Report of a case. J Oral Maxillofac Surg 67 (2009) 402-405
27. Robertson A., Mansberg T., Mansberg V., Van der All H., and Hooper M. Tumor-induced osteomalacia: a case of diagnostic dilemma. Clin Nucl Med 32 8 (2007) 631-632
28. Jan de Beur S.M. Tumor-induced osteomalacia. JAMA 294 10 (2005) 1260-1267
29. Roarke M.C., and Nguyen B.D. PET/CT localization of phosphaturic mesenchymal neoplasm causing tumor-induced osteomalacia. Clin Nucl Med 32 4 (1997) 300-301
30. Cheung F.M.F., Ma L., Wu W.C., Siu T.H., Choi P.T., and Tai Y.P. Oncogenic osteomalacia associated with an occult phosphaturic mesenchymal tumour: clinico-radiologico-pathological correlation with ultrastructural studies. Hong Kong Med J 12 4 (2006) 319-321
31. Shane E., Parisien M., Henderson J.E., Dempster D.W., Feldman F., Hardy M.A., et al. Tumor-induced osteomalacia: clinical and basic studies. J Bone Miner Res 12 (1997) 1502-1511
32. Kumar R. Tumor-induced osteomalacia and the regulation of phosphate homeostasis. Bone 27 3 (2000) 333-338
33. Mirams M., Robinson B.G., Mason R.S., and Nelson A.E. Bone as a source of FGF23: regulation by phosphate?. Bone 35 (2004) 1192-1199
34. Jonsson K.B., Mannstadt M., Miyauchi A., Yang I.M., Stein G., Ljunggren Ö., et al. Extracts from tumors causing oncogenic osteomalacia inhibit phosphate uptake in opossum kidney cells. J Endocrinol 169 (2001) 613-620
35. Wilkins G.E., Granleese S., Hegele R.G., Holden J., Anderson D.W., and Bondy G.P. Oncogenic osteomalacia: evidence for a humoral phosphaturic factor. J Clin Endocrinol Metab 80 5 (1995) 1628-1634
36. Shimada T., Hasegawa H., Yamazaki Y., Muto T., Hino R., Takeuchi Y., et al. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19 (2004) 429-435
37. ADHR Consortium. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet 26 3 (2000) 345-348
38. Shimada T., Mizutani S., Muto T., Yoneya T., Hino R., Takeda S., et al. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci U S A 98 11 (2001) 6500-6505
39. Koriyama N., Nishimoto K., Kodama T., Nakazaki M., Kurono Y., Yoshida H., et al. Oncogenic osteomalacia in a case with a maxillary sinus mesenchymal tumor. Am J Med Sci 332 3 (2006) 142-147
40. White K.E., Jonsson K.B., Carn G., Hampson G., Spector T.D., Mannstadt M., et al. The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting. J Clin Endocrinol Metab 86 (2001) 497-500
41. Paul S., Kurtz M., and Mentzer S.J. Osteomalacia associated with fibroblast growth factor-23 secreting chest wall tumor. J Thorac Cardiovasc Surg 134 3 (2007) 803-804
42. Takeuchi Y., Suzuki H., Ogura S., Imai R., Yamazaki Y., Yamashita T., et al. Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia. J Clin Endocrinol Metab 89 (2004) 3979-3982
43. Carpenter T.O., Ellis B.K., Insogna K.L., Philbrick W.M., Sterpka J., and Shimkets R. FGF7 - an inhibitor of phosphate transport derived from oncogenic osteomalacia-causing tumors. J Clin Endocrinol Metab 90 2 (2005) 1012-1020
44. Ryan E.A., and Reiss E. Oncogenous osteomalacia. Review of the world literature of 42 cases and report of two new cases. Am J Med 77 (1984) 501-512
45. Seufert J., Ebert K., Muller J., Eulert J., Hendrich C., Werner E., et al. Octreotide therapy for tumor-induced osteomalacia. N Engl J Med 345 (2001) 1883-1888